The protein expression of Bcl-2, Bax, Fas/Apo-1 in acute myeloid leukemia

J Tongji Med Univ. 1998;18(1):42-5. doi: 10.1007/BF02888279.

Abstract

The protein expression of bcl-2, bax, Fas/Apo-1 in 19 cases of acute myeloid leukemia (AML) were investigated by Western blot and ApAAp techniques. High expression of bcl-2 protein was found in most of the AML cases, and some of the cases expressed Fas/Apo-1 and bax. High expression of bcl-2 protein was associated with a bad clinical prognosis and a poor response after intensive chemotherapy. Bax seemed to coexpress with bcl-2 and so appeared to be a bad prognostic factor instead of a good one. The expression of Fas/Apo-1 was inversely correlated with bcl-2 and seemed to be a good prognostic factor which may reflect the relative homeostasis of apoptotic pathway. It is concluded that apoptosis-induced pathways in AML often exhibit disturbance features. Coregulation of bcl-2, Bax and Fas/Apo-1 genes formed the apoptosis-induced pathway, which is the biological factor affecting response to chemotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Adolescent
  • Adult
  • Aged
  • Apoptosis
  • Apoptosis Regulatory Proteins
  • Carrier Proteins / biosynthesis
  • Female
  • Genes, bcl-2
  • Humans
  • Leukemia, Monocytic, Acute / genetics
  • Leukemia, Myeloid, Acute / genetics*
  • Leukemia, Myelomonocytic, Acute / genetics*
  • Male
  • Middle Aged
  • Proto-Oncogene Proteins / biosynthesis*
  • Proto-Oncogene Proteins c-bcl-2 / biosynthesis*
  • bcl-2-Associated X Protein

Substances

  • Adaptor Proteins, Signal Transducing
  • Apoptosis Regulatory Proteins
  • BAX protein, human
  • Carrier Proteins
  • FAF1 protein, human
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • bcl-2-Associated X Protein